Towards effective CAIX-targeted radionuclide and checkpoint inhibition combination therapy for advanced clear cell renal cell carcinoma.
Kleinendorst SC, Oosterwijk E, Molkenboer-Kuenen J, Frielink C, Franssen GM, Boreel DF, Tamborino G, Gloudemans M, Hendrikx M, Kroon D, Hillen J, Bussink J, Muselaers S, Mulders P, Konijnenberg MW, Wheatcroft MP, Twumasi-Boateng K, Heskamp S.
Kleinendorst SC, et al. Among authors: kroon d.
Theranostics. 2024 Jun 11;14(9):3693-3707. doi: 10.7150/thno.96944. eCollection 2024.
Theranostics. 2024.
PMID: 38948062
Free PMC article.